Call 888-647-0579 to speak with an alcohol or drug abuse counselor.

Who Answers?

New Medications May Offer Hope to Drinkers Battling Alcohol Dependence

Individuals who experience the physical, mental and social symptoms associated with alcohol dependence are offered hope through the results of two recent studies by researchers at the Medical University of South Carolina (MUSC). In separate investigations, researchers found favorable results for a medication to help heavy drinkers who are trying to modify their consumption, as well as a medication to reduce alcohol withdrawal symptoms and prevent relapse.

In a landmark study, MUSC researchers working with investigators at the University of Virginia Health System and elsewhere have found that topiramate, an effective therapeutic medication, not only decreases heavy drinking, but it also lowers all liver enzymes, plasma cholesterol, body mass index (BMI), and systolic and diastolic blood pressure — all of which tend to increase with heavy drinking and pose such serious health risks as heart disease and cirrhosis. Notably, these combined effects suggest that topiramate may decrease the risk of heart disease in alcohol dependent individuals.

“These findings add growing data indicating that heavy drinkers who modify their drinking with the help of medication and supportive counseling may see an improvement in health and well-being, as well as a potential reduction of risk for the development of heart and liver diseases. This shows that treatment of alcoholism has potential health benefits beyond the immediate behavioral and emotional improvement caused by a reduction in drinking” said Raymond Anton, M.D., distinguished university professor.

By decreasing liver enzymes and cholesterol levels, topiramate also may reduce the risk of fatty liver disease, which leads to cirrhosis – a common consequence to end-stage liver disease leading to death in some alcoholics.

Additionally, topiramate significantly contributed to a decline in obsessive thoughts and compulsions, components of alcohol craving, and also had a greater improvement in their “overall quality of life,” and specifically an improvement in general and leisure activities and household duties, as well as a reduction in sleep disturbances.

The Food and Drug Administration has approved topiramate for seizures and migraine headaches, but it is not currently approved for treating alcohol dependence. Ortho-McNeil Neurologics, Inc., manufactures topiramate and provided study funding.

Results from the nationwide 14-week trial involving 371 male and female diagnosed alcoholics was published in the June 9 issue of the Archives of Internal Medicine.

In addition, Anton presented initial results from a separate investigation of a 14-week double-blind, placebo-controlled study utilizing the PROMETA ® alcoholism treatment program, developed by Hythiam, inc., at the 2008 Research Society on Alcoholism (RSA) conference in Washington D.C.

Anton suggested that alcohol dependence programs are few in number and not exceptionally effective, which is particularly true for individuals who experience alcohol withdrawal symptoms. PROMETA ®, a combination of generic medications, reduced cravings and alcohol withdrawal symptoms, promoted abstinence, and improved mood and sleep only in those who had symptoms of alcohol withdrawal. Although the PROMETA ® Protocol has been marketed nationally, this was the first scientific study examining its utility in individuals with alcohol dependence.

At the time of the RSA presentation, the data presented covered the initial six-week active treatment phase of the 14-week study. While these are initial findings, additional evaluation of the full 14-week study data is ongoing, and Anton plans to release these specifics in a peer-reviewed publication.

MUSC has an ongoing clinical trial program studying new medications for the treatment of alcohol use disorders. For more information call 843-792-2727.
__________
source: Newswise Medical News

More Treatment & Detox Articles

Quaker faith helps alcoholic to quit drinking

A recovered alcoholic from Maldon said he has his Quaker faith to thank for helping him stay alive. Anthony told BBC Essex’s Ian Wyatt he started to drink when he was 20, shortly after joining the Air Force. Having had a religious upbringing as a Pentecostalist, he had never previously drank or smoked. After 25….

Brain imaging study offers insight into alcohol's effect on brain

A new brain imaging study has provided insight into alcohol’s effect on the brain. The study showed that after consuming alcohol, social drinkers had decreased sensitivity in brain regions involved in detecting threats, and increased activity in brain regions involved in reward. This is the first human brain imaging study of alcohol’s effect on the….

Major Report Finds Screening and Early Intervention Program Used in Diverse Health Care Settings Dramatically Reduces Illicit Drug Use among Patients

Report found a 67.7 percent reduction in illicit drug use over a six month period among people receiving these services The Screening, Brief Intervention, and Referral to Treatment (SBIRT) program can reduce illicit drug use among patients seeking medical care in a wide variety of health care settings such as hospitals, physician offices, and community….

Doctors want booze marketing ban

There should be a ban on all alcohol advertising, including sports and music sponsorship, doctors say. The British Medical Association said the crackdown on marketing was needed, along with an end to cut-price deals, to stop rising rates of consumption. The industry spends £800m a year on promoting drinks – just a quarter of which….

Take it from a former binge drinker

The ancient Egyptian text of the Papyrus Antastasi gave a look into the satirical, yet advanced minds of society. One quote from this text said the following: “Don’t undertake to drink a whole pitcher of beer. Because if you then talk, from your mouth comes nonsense.” Didn’t we learn anything from the ancient Egyptians? Drinking….